{"organizations": [], "uuid": "9bb5190d0dc3856d1db60305f6908e2be1fba1bf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-vascepa-showed-fall-in-atherogenic/brief-vascepa-showed-fall-in-atherogenic-lipid-inflammatory-markers-in-statin-treated-patients-with-reduced-kidney-function-idUSFWN1RP06V", "country": "US", "domain_rank": 408, "title": "BRIEF-Vascepa Showed Fall In Atherogenic Lipid, Inflammatory Markers In Statin Treated Patients With Reduced Kidney Function", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T12:10:00.000+03:00", "replies_count": 0, "uuid": "9bb5190d0dc3856d1db60305f6908e2be1fba1bf"}, "author": "", "url": "https://www.reuters.com/article/brief-vascepa-showed-fall-in-atherogenic/brief-vascepa-showed-fall-in-atherogenic-lipid-inflammatory-markers-in-statin-treated-patients-with-reduced-kidney-function-idUSFWN1RP06V", "ord_in_thread": 0, "title": "BRIEF-Vascepa Showed Fall In Atherogenic Lipid, Inflammatory Markers In Statin Treated Patients With Reduced Kidney Function", "locations": [], "entities": {"persons": [], "locations": [{"name": "atherogenic lipid", "sentiment": "none"}, {"name": "atherogenic lipid", "sentiment": "none"}], "organizations": [{"name": "brief-vascepa showed fall in atherogenic lipid", "sentiment": "negative"}, {"name": "amarin corporation plc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 12 (Reuters) - Amarin Corporation PLC:\n* VASCEPA SHOWED FALL IN ATHEROGENIC LIPID, INFLAMMATORY MARKERS IN STATIN-TREATED PATIENTS WITH REDUCED KIDNEY FUNCTION, PERSISTENT HIGH TRIGLYCERIDES Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-04-12T12:10:00.000+03:00", "crawled": "2018-04-12T12:31:07.001+03:00", "highlightTitle": ""}